• uconn
  • uconn health
Page content relevant to:

Foreign Collaborations

International Relationships, Foreign Components and Sponsored Programs

UConn encourages international collaborations and the OVPR strongly urges investigators to err on the side of transparency in disclosing these collaborations to the University and Sponsors.

Government Concern

  1. The National Institutes of Health (NIH) issued a Notice on March 30, 2018, reminding research institutions that PIs, sub-awardees and co-PIs must disclose all financial interests received from higher education or governmental institutions in countries outside the United States (NOT-OD-18-160). NIH Director Dr. Francis S. Collins also sent a memo to institutions on Aug. 20, 2018, stating that the failure to properly disclose foreign relationships threatened to distort decision-making about the use of NIH funds.
  2. The National Defense Authorization Act, signed in August 2018, included Sec. 1286, which stated that “The Secretary of Defense shall, in consultation with other appropriate government organizations, establish an initiative to work with academic institutions who perform defense research and engineering activities . . . to limit undue influence, including through foreign talent programs, by countries to exploit United State Technology … ”
  3. The National Science Board issued a statement on “Security and Science” dated October 23, 2018, stating that US universities must “embrace transparency and rigorously adhere to conflict of interest and conflict of commitment policies.”
  4. The Department of Energy issued a notification on February 1, 2019, stating that DOE plans to implement a policy, which will mandate that “federal and contractor personnel fully disclose and, as necessary, terminate affiliations with foreign government-supported talent recruitment programs.”
  5. As a reminder, NASA has long-standing restrictions on using NASA funds to enter into agreements “to participate, collaborate, or coordinate bilaterally in any way with China or any Chinese-owned company, at the prime recipient level or at any subrecipient level, whether the bilateral involvement is funded or performed under a no-exchange of funds arrangement” (grant restrictions, contract restrictions).

Foreign Components

Foreign components of federally funded research should be disclosed in proposals, progress reports, and final technical reports. Under the NIH Grants Policy Statement, a Foreign Component is defined as “any significant scientific element or segment of a project outside of the United States, either by the recipient or by a researcher employed by a foreign organization, whether or not grant funds are expended”. The definition of “foreign component” (which can be found here) may include a large number of collaborative activities, including “collaborations with investigators at a foreign site anticipated to result in co-authorship; use of facilities or instrumentation at a foreign site; or receipt of financial support or resources from a foreign entity.” Other sponsors have similar requirements to disclose foreign components.

NIH Policy on Foreign Component

  • Foreign Other support must be disclosed to the NIH in advance by including it in the Just-in-Time Other Support submission on a new or renewal award, or updated in the annual RPPR, or submitted by letter to the awarding office and thereafter included in the RPPR.
  • Foreign Components applies to NIH work scope performed in a foreign location, either funded by the NIH grant or by other sources, domestic or foreign.

Foreign Payments

The University’s Consulting Policy  requires prior approval of any remuneration, compensation, honorarium, stipends, non-university salary, or other similar payments for providing consulting, advice, services, support or other similar activities from any source, including foreign entities or persons.  The University’s Financial Conflicts of Interest in Research Policy requires disclosure of remuneration, compensation, honorarium, stipends, non-university salary, or other similar payments totaling over $5,000 in a 12 month period from a single entity, and any paid or reimbursed travel totaling over $5000 in a 12 month period by a single entity.  This include any foreign entity (e.g. governments and institutions) or persons.

Current and Other Support 

“Other Support” includes all financial resources, domestic or foreign, available in direct support of a researcher’s research endeavors.  Such support should be disclosed on an “Other Support” or “Current & Pending” form.   See here for guidance.

Importance

It protects everyone’s interests – the Federal government, UConn, individual investigators, and their international collaborators – to have international relationships disclosed and vetted to determine if there are any potential conflict of commitments, duplications of research, and/or diversion of intellectual property in the performance of federally funded research.

In some cases, failure to disclose all relationships could result in the termination of funding for a project and potential ineligibility for future funding. Noncompliance can also threaten not only the funding for individual projects, but overall funding for the University.

How to Get Assistance?

Faculty and investigators who have questions or concerns about disclosure requirements should contact the OVPR for guidance and assistance.

Contact the OVPR